Skip to main navigation Skip to search Skip to main content

Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia

  • M. Bassetti
  • , Enrico Maria Trecarichi
  • , A. Mesini
  • , Teresa Spanu Pennestri
  • , D. R. Giacobbe
  • , M. Rossi
  • , E. Shenone
  • , Gennaro De Pascale
  • , M. P. Molinari
  • , Roberto Cauda
  • , C. Viscoli
  • , Mario Tumbarello
  • University of Genoa
  • San Martino Hospital Genoa

Research output: Contribution to journalArticle

Abstract

Staphylococcus aureus bacteraemia (SAB) is a leading cause of mortality and morbidity in both nosocomial and community settings. The objective of the study is to explore epidemiological characteristics and predisposing risk factors associated with healthcare-associated (HCA) and community-acquired (CA) SAB, and to evaluate any differences in mortality and efficacy of initial antimicrobial therapy on treatment outcome. We conducted a two-part analysis. First, a triple case-control study in which groups of HCA SAB with onset ≥ 48 h after hospital admission (HCA ≥ 48 h), HCA SAB with onset <48 h of hospital admission (HCA <48 h), and CA SAB were compared with controls. Second, a cohort study including all patients with SAB was performed to identify factors associated with in-hospital mortality. SAB was diagnosed in 165 patients over the study period (January 2007 to December 2007). Five variables were independently associated with HCA ≥ 48 h SAB: presence of central venous catheter, solid tumour, chronic renal failure, previous hospitalization and previous antibiotic therapy. Significant risk factors for HCA <48 h SAB were: Charlson Comorbidity Index ≥ 3, previous hospitalization, living in long-term care facilities and corticosteroid therapy. Factors independently associated with CA SAB were: diabetes mellitus, HIV infection and chronic live disease. Patients with HCA <48 h SAB were significantly more likely to receive initial inadequate antimicrobial treatment than patients with CA or HCA ≥ 48 h SAB (44.8% versus 33.3% and 31.5%, respectively). Logistic-regression analysis identified three variables as independent predictors of mortality: presentation with septic shock, infection with methicillin-resistant S. aureus, and initial inadequate antimicrobial treatment. More than half of patients with SAB have MRSA strains and presentation with septic shock, and inappropriate empirical therapy was associated with increased mortality.
Original languageEnglish
Pages (from-to)862-869
Number of pages8
JournalClinical Microbiology and Infection
Volume18
DOIs
Publication statusPublished - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Staphylococcus aureus
  • bacteraemia
  • community-acquired (CA)
  • healthcare-associated (HCA)
  • initial antimicrobial therapy
  • methicillin-resistant S. aureus (MRSA)
  • mortality
  • septic shock

Fingerprint

Dive into the research topics of 'Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia'. Together they form a unique fingerprint.

Cite this